In drug design one attempts to correlate the three–dimensional structure of drug molecules with their biochemical activity. A frequent objective is to find molecules with a high binding affinity towards a certain target protein of therapeutic importance. If no structural information about the target protein is available, putative ligands are often superimposed with the structure of a reference ligand which is know
Structural biologists focus on the structure of biomolecules. Several techniques are available to st...
The availability of three-dimensional spatial information about protein structures is expanding, as ...
Successful structure-based drug design (SBDD) requires the optimization of interactions with the tar...
The majority of drug targets for small molecule therapeutics are proteins whose three-dimensional st...
In drug design, often enough, no structural information on a particular receptor protein is availabl...
In recent years an effort has been made to supplement traditional methods for drug discovery by comp...
The three-dimensional shape of a protein plays a key role in determining its function, so proteins i...
This thesis is concerned with developing statistical methods for evaluating and comparing molecular ...
In recent years, research area of structure-based drug design is a rising field that has been used t...
Three-dimensional quantitative structure–activity relationships (3D-QSAR) analyses are methods corre...
Pharmacophoresthree-dimensional (3D) arrangements of essential features enabling a molecule to exert...
We present the global mapping of pharmacological space by the integration of several vast sources of...
Structure-based drug design is now a common method used by the pharmaceutical industry to identify a...
Abstract: Ligand docking checks whether a drug chemical called ligand matches the target receptor pr...
The rapid pace of scientific advances is enabling a greater understanding of diseases at the molecul...
Structural biologists focus on the structure of biomolecules. Several techniques are available to st...
The availability of three-dimensional spatial information about protein structures is expanding, as ...
Successful structure-based drug design (SBDD) requires the optimization of interactions with the tar...
The majority of drug targets for small molecule therapeutics are proteins whose three-dimensional st...
In drug design, often enough, no structural information on a particular receptor protein is availabl...
In recent years an effort has been made to supplement traditional methods for drug discovery by comp...
The three-dimensional shape of a protein plays a key role in determining its function, so proteins i...
This thesis is concerned with developing statistical methods for evaluating and comparing molecular ...
In recent years, research area of structure-based drug design is a rising field that has been used t...
Three-dimensional quantitative structure–activity relationships (3D-QSAR) analyses are methods corre...
Pharmacophoresthree-dimensional (3D) arrangements of essential features enabling a molecule to exert...
We present the global mapping of pharmacological space by the integration of several vast sources of...
Structure-based drug design is now a common method used by the pharmaceutical industry to identify a...
Abstract: Ligand docking checks whether a drug chemical called ligand matches the target receptor pr...
The rapid pace of scientific advances is enabling a greater understanding of diseases at the molecul...
Structural biologists focus on the structure of biomolecules. Several techniques are available to st...
The availability of three-dimensional spatial information about protein structures is expanding, as ...
Successful structure-based drug design (SBDD) requires the optimization of interactions with the tar...